Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free public preview Track OSTX with free AI briefings, catalyst countdowns, and dilution alerts.

OSTX

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$917,552 Cash on Hand
0.7mo Cash Runway
4% Short Interest

🧪 Upcoming Trial Catalysts

💰 Cash Runway & Dilution Risk

OSTX holds $917,552 in cash and burns about $4.1M/quarter from operations, giving an estimated runway of 0.7 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for OSTX free →

📈 Recent Insider Activity (Form 4)

DateInsiderTypeValue
2026-02-13 PETIT ROBERT
Purchase $0
2026-02-13 Jarry Olivier Roger
Purchase $0
2026-02-13 Galzahr Karim
Purchase $0
2026-02-13 Romness Paul A.
Purchase $0
2026-02-13 Acevedo Christopher P.
Purchase $0

Get the full OSTX picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for OSTX and 2 more tickers of your choice.

Create Free Account →
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.